Ross Givens
Chief Market Strategist
Ross Givens is a veteran trader with over 15 years of experience and a former VP at a major Wall Street investment bank. Specializing in small-cap stocks and momentum-driven plays, Ross identifies high-probability setups before they hit the mainstream. As Lead Strategist at Traders Agency, he has guided hundreds of successful trades and developed multiple flagship publications.
Wall Street's Forced Buying Just Started... These Stocks Are NEXT
Forced index buying sends stocks surging 20%+ overnight. See how Russell 2000 rebalancing creates mechanical buying -- and which stocks are positioned next
Time to Put Your Foot on the Gas
The hottest trade in the market may be changing character. And when momentum starts to crack, late buyers can get trapped fast.
Ready for a Small-Cap Summer?
The hottest trade in the market may be changing character. And when momentum starts to crack, late buyers can get trapped fast.
The Smart Money Just Moved... BUY These 2 NOW
Smart money biotech stocks are taking the lead as capital rotates out of semis. IMVT and TGTX show tight setups with institutional money flow backing the m
Why You MUST be a Market Timer in Q3
The hottest trade in the market may be changing character. And when momentum starts to crack, late buyers can get trapped fast.
The Next GameStop Could Be This $13 Stock
The next GameStop meme stock may already be forming. Jack in the Box has tiny float, high short interest, and WallStreetBets attention — the exact GME setu
Q3 Volatility Spike Incoming?
The hottest trade in the market may be changing character. And when momentum starts to crack, late buyers can get trapped fast.
Forget Oil... These 3 Shipping Stocks Are PRINTING Money
Oil tanker stocks are quietly minting cash as VLCC day rates hit $470K/day — triple last month's levels. Here's why falling oil prices mean rising tanker p
Is the Semiconductor Trade Over? (What to do Instead)
The hottest trade in the market may be changing character. And when momentum starts to crack, late buyers can get trapped fast.
The FDA Decides July 7... Wall Street Thinks This $35 Stock Doubles
Vera Therapeutics stock faces an FDA decision July 7. Phase 3 crushed expectations with 46% kidney protein reduction. Wall Street targets $83.50 on this $3
Will the Fed Crush the Stock Market?
The SpaceX IPO is going LIVE today. What’s going to happen next – and does the massive hype mark the “top” for the market? Find out inside.
The Government Just Bet $2 Billion On Quantum... These 2 Stocks Are Next
Government quantum computing investment just hit $2B across 9 private firms. These 2 picks-and-shovels stocks sit in the direct path of that funding.
Stop watching.
Start winning.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.
